1.	Biological Therapy in Treating Patients With Stage I, Stage II, or Stage III Pancreatic Cancer That Has Been Surgically Removed Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000066460, DUMC-97093, NCI-G98-1457, NCT00003434
2.	Phase I Study of Carcinoembryonic Antigen Peptide-1 (CAP) and DetoxPC for Adenocarcinomas of the Gastrointestinal Tract, Breast, and Lung (Summary Last Modified 09/1999) Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-96-C-0139, NCI-NMOB-9305, NCI-T96-0058N, T96-0058
3.	Phase I Pilot Study of Active Immunotherapy with Carcinoembryonic Antigen (CEA) Peptide-Pulsed Autologous Dendritic Cells in Metastatic Adenocarcinomas That Express CEA (Summary Last Modified 12/1999) Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: DUMC-96024, NCI-H96-1110
4.	Phase I Study of Recombinant Carcinoembryonic Antigen (CEA) Vaccinia Virus Vaccine With Post Vaccination CEA Peptide Challenge in Patients With Malignant Solid Tumors (Summary Last Modified 04/2000) Phase: Phase I Type: Treatment Status: Completed Age: over 18 Sponsor: NCI Protocol IDs: MUSC-6124, NCI-T95-0044, T95-0044